Abstract:The application of cancer gene therapy has heretofore been restricted to local, or locoregional, neoplastic disease contexts. This is owing to the lack of gene transfer vectors, which embody the requisite target cell selectivity in vivo required for metastatic disease applications. To this end, we have explored novel vector engineering paradigms to adapt adenovirus for this purpose. Our novel strategy exploits three distinct targeting modalities that operate in functional synergy. Transcriptional targeting is achieved via the hROBO4 promoter, which restricts transgene expression to proliferative vascular endothelium. Viral binding is modified by incorporation of an RGD4C peptide in the HI loop of the fiber knob for recognition of cellular integrins. Liver sequestration is mitigated by ablation of factor X binding to the major capsid protein hexon by a serotype swap approach. The combination of these technologies into the context of a single-vector agent represents a highly original approach. Studies in a murine model of disseminated cancer validated the in vivo target cell selectivity of our vector agent. Of note, clear gains in therapeutic index accrued these vector modifications. Whereas there is universal recognition of the value of vector targeting, very few reports have validated its direct utility in the context of cancer gene therapy. In this regard, our article validates the direct gains that may accrue these methods in the stringent delivery context of disseminated neoplastic disease. Efforts to improve vector targeting thus represent a critical direction to fully realize the promise of cancer gene therapy.

Advance in Gene Therapy of Tumors

Advancement and prospects of tumor gene therapy

Gene Therapy:the Present and Prospect

Gene Therapy: Regulations, Ethics and Its Practicalities in Liver Disease

Recent Developments in the Use of Adenoviruses and Immunotoxins in Cancer Gene Therapy

Section Review—Oncologic, Endocrine & Metabolic: Gene Therapy Strategies for Cancer

The problem and progress of gene therapy vectors of tumor in clinical application

Advanced gene therapy system for the treatment of solid tumour: A review

Research Progress of Gene Therapy in Clinical Application

Gene therapy in solid tumors: trends in trials in China and beyond

Vector engineering, strategies and targets in cancer gene therapy

Research Progress on Gene Editing Based on Nano-Drug Delivery Vectors for Tumor Therapy

Current status of gene therapy vector research

Gene Therapy for Cancer: What Have We Done and Where Are We Going?

Advances in tumor immunotherapy and gene therapy

Progress of Application of Gene Transfer System in Therapy of Angiogenesis

[Nanobiotechnological Gene Transfer Vectors in Gene Therapy].

Development and clinical translation of ex vivo gene therapy

Advancements of gene therapy in cancer treatment: A comprehensive review

Targeting Tumor Neoangiogenesis via Targeted Adenoviral Vector to Achieve Effective Cancer Gene Therapy for Disseminated Neoplastic Disease

Advancements in p53-Based Anti-Tumor Gene Therapy Research